A multiple myeloma treatment offers hope, but has a high cost. A Houston trial aims to make this life-saving therapy ...

the overall survival for the observation cohort was worse than overall survival in some contemporary myeloma trials. In my opinion, daratumumab can improve asymptomatic laboratory and imaging ...

To test for signs of kidney damage and multiple myeloma, a healthcare provider may ask you to collect all of your urine over 24 hours. They will then send the 24-hour sample to a lab for testing.

Dr. Rahul Banerjee is a physician-researcher who specializes in multiple myeloma, a blood cancer caused by plasma cells that can cause bone and kidney damage. Dr. Banerjee also treats patients with AL ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...

An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.

Multiple myeloma is a relatively uncommon cancer of plasma cells, where excessive proliferation of these malignant cells within the bone marrow leads to abnormal antibody production. The disease ...

Multiple myeloma (MM) is a blood cancer that affects plasma cells in bone marrow. It’s a particularly insidious form of ...

Forty-eight patients with multiple myeloma, most of them ambulatory outpatients, at 5 co-operating hospitals,‡ were treated. Patients were entered in the double-blind study by randomized card ...

Thalidomide was the first immunomodulatory agent approved for use in myeloma. Although highly active, it is associated with considerable toxicity, particularly in older patients. Lenalidomide ...